Literature DB >> 20399654

Synthesis of novel benzocoumarin derivatives as lipid lowering agents.

Koneni V Sashidhara1, Jammikuntla N Rosaiah, Abdhesh Kumar, Gitika Bhatia, A K Khanna.   

Abstract

A series of novel benzocoumarin derivatives were synthesized and evaluated for their in vivo anti-dyslipidemic and in vitro antioxidant activities. Preliminary screening indicates compound 4 as potential lead with significant lipid lowering and antioxidant activities. The study revealed that such attempts on benzocoumarin-based pharmacophores which is a biologically important scaffold might result in identification of new lead for anti-dyslipidemia. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20399654     DOI: 10.1016/j.bmcl.2010.03.103

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Bergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination.

Authors:  M L Panno; F Giordano; P Rizza; M Pellegrino; D Zito; C Giordano; L Mauro; S Catalano; S Aquila; D Sisci; F De Amicis; A Vivacqua; S W A Fuqua; S Andò
Journal:  Breast Cancer Res Treat       Date:  2012-10-09       Impact factor: 4.872

2.  Esculin and its oligomer fractions inhibit adhesion and migration of U87 glioblastoma cells and in vitro angiogenesis.

Authors:  Imen Mokdad-Bzeouich; Hervé Kovacic; Kamel Ghedira; Latifa Chebil; Mohamed Ghoul; Leila Chekir-Ghedira; José Luis
Journal:  Tumour Biol       Date:  2015-10-12

3.  Pentafluorophenylammonium triflate (PFPAT) catalyzed facile construction of substituted chromeno[2,3-d]pyrimidinone derivatives and their antimicrobial activity.

Authors:  Majid Ghashang; Syed Sheik Mansoor; Krishnamoorthy Aswin
Journal:  J Adv Res       Date:  2013-03-20       Impact factor: 10.479

4.  Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells.

Authors:  Safaa M Kishk; Enas E Eltamany; Mohamed S Nafie; Roaa M Khinkar; Rawan H Hareeri; Sameh S Elhady; Asmaa S A Yassen
Journal:  Molecules       Date:  2022-10-09       Impact factor: 4.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.